Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference

Rhea-AI Summary

Repligen Corporation (NASDAQ:RGEN) will present virtually at the 11th Annual SVB Leerink Healthcare Conference from Feb. 14-18, 2022. Tony J. Hunt, President and CEO, is scheduled for a fireside chat on Feb. 18 at 3:00 p.m. EST. A live webcast will be available on Repligen's Investor Relations page and will be accessible for replay shortly after the event.

The company is a leader in bioprocessing technology, enhancing efficiencies for biopharmaceutical manufacturers.

WALTHAM, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 11th Annual SVB Leerink Healthcare Conference being held Feb. 14-18, 2022.  Tony J. Hunt, President and Chief Executive Officer, will participate in a fireside chat on Friday, Feb. 18, at 3:00 p.m. EST.

A live webcast of the presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. We are inspiring advances in bioprocessing for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. we have sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company, including Repligen news releases, see our website at www.repligen.com. Follow us on LinkedIn and Twitter.

Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com

FAQ

What is Repligen Corporation's presentation at the 11th Annual SVB Leerink Healthcare Conference about?

Repligen Corporation will present at the conference focusing on its bioprocessing technologies.

When is Tony J. Hunt's fireside chat at the SVB Leerink Healthcare Conference?

Tony J. Hunt's fireside chat is scheduled for February 18, 2022, at 3:00 p.m. EST.

How can I access the webcast of Repligen's presentation at the conference?

The webcast can be accessed through Repligen's Investor Relations website.

What technologies does Repligen Corporation specialize in?

Repligen specializes in developing bioprocessing technologies for biological drug manufacturing.

What is the stock symbol for Repligen Corporation?

The stock symbol for Repligen Corporation is RGEN.